BioSpace News Archive

Press Releases

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025

February 5, 2025
·
1 min read
Press Releases

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025

February 5, 2025
·
4 min read
Press Releases

Annovis Bio, Inc. Announces Closing of $21 Million Public Offering

February 5, 2025
·
3 min read
Press Releases

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025

February 5, 2025
·
1 min read
Press Releases

Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

February 5, 2025
·
4 min read
Press Releases

China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment

February 5, 2025
·
3 min read
Press Releases

Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan

February 5, 2025
·
6 min read
Press Releases

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

February 5, 2025
·
1 min read
Press Releases

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

February 5, 2025
·
1 min read
Press Releases

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

February 5, 2025
·
16 min read